Bayer, Sun Pharma sign marketing and distribution agreement for second brand of Finerenone in India
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients
The Institute is catering the health needs of the surrounding population with ever-increasing OPD every year along with special OPDs like mother & Child OPD, and LSD clinic
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US
Argo will receive upfront payments of US$ 185 million from Novartis and is eligible to receive potential option and milestone payments as well as tiered royalties on commercial sales.
Subscribe To Our Newsletter & Stay Updated